Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice

Vaishya Richa1, Gupta Rahul, Arora Sarika

  • 1Guru Nanak Eye Center, New Delhi, India.

Abstract

Insights

Macroprolactin, a non-bioactive form of prolactin, often causes misdiagnosis in hyperprolactinemia patients. Awareness and improved diagnostic methods are crucial for accurate patient care.

Area of Science:

  • Endocrinology
  • Clinical Chemistry

Background:

  • Macroprolactin is a common cause of misdiagnosis and inappropriate treatment in hyperprolactinemia.
  • Technical difficulties hinder macroprolactin identification, leading to unawareness among clinicians and labs.
  • Interference of macroprolactin in prolactin assays is a significant clinical challenge.

Purpose of the Study:

  • To review the current understanding of macroprolactinemia.
  • To highlight the diagnostic challenges and clinical implications of macroprolactin.
  • To emphasize the need for updated diagnostic and pathophysiological knowledge.

Main Methods:

  • A comprehensive literature search was performed.
  • Databases searched included PubMed Central and the National Library of Medicine.
  • Relevant books and journals were also consulted.

Main Results:

  • Macroprolactin is a non-bioactive prolactin isoform, typically a prolactin monomer bound to an IgG molecule.
  • It exhibits prolonged clearance, similar to immunoglobulins.
  • This isoform is clinically non-reactive but interferes with immunological prolactin assays.

Conclusions:

  • There is a critical need to enhance understanding of macroprolactinemia.
  • Recent advancements in diagnosis and pathophysiology require exploration.
  • Improving patient care necessitates better awareness and diagnostic strategies for macroprolactin.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...